Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease (COVID-19) which has recently emerged as a potential threat to global public health. SARS-CoV-2 is the third known human coronavirus that has huge impact on the human population after SARS-CoV...

Full description

Bibliographic Details
Main Authors: Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Phongthon Kanjanasirirat, Priyo Budi Purwono, Kaewta Rattanapisit, Balamurugan Shanmugaraj, Duncan R. Smith, Suparerk Borwornpinyo, Arunee Thitithanyanont, Waranyoo Phoolcharoen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Plant Science
Subjects:
COVID-19
SARS-CoV-2
ACE2-Fc fusion protein
molecular farming
Nicotiana benthamiana
plant-produced recombinant protein
Online Access:https://www.frontiersin.org/articles/10.3389/fpls.2020.604663/full

Internet

https://www.frontiersin.org/articles/10.3389/fpls.2020.604663/full

Similar Items